☰

Helena A. Harlin, Ph.D. - Publications

Institution:
University of Chicago, Chicago, IL
Tree Info Similar researchers PubMed Report error

17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2009 Harlin H, Meng Y, Peterson AC, Zha Y, Tretiakova M, Slingluff C, McKee M, Gajewski TF. Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment. Cancer Research. 69: 3077-85. PMID 19293190 DOI: 10.1158/0008-5472.Can-08-2281  0.483
2009 Knight D, Peterson AC, Rini BI, Harlin H, Gajewski TF, Stadler WM. The HLA-A2-restricted PSMA peptide LLHETDSAV is poorly immunogenic in patients with metastatic prostate cancer. The Prostate. 69: 142-8. PMID 18942640 DOI: 10.1002/Pros.20864  0.33
2007 Gajewski T, Meng Y, Harlin H. Chemokines expressed in melanoma metastases associated with T cell infiltration Journal of Clinical Oncology. 25: 8501-8501. DOI: 10.1200/Jco.2007.25.18_Suppl.8501  0.443
2006 Gajewski TF, Meng Y, Blank C, Brown I, Kacha A, Kline J, Harlin H. Immune resistance orchestrated by the tumor microenvironment. Immunological Reviews. 213: 131-45. PMID 16972901 DOI: 10.1111/J.1600-065X.2006.00442.X  0.45
2006 Meng Y, Harlin H, O'Keefe JP, Gajewski TF. Induction of cytotoxic granules in human memory CD8+ T cell subsets requires cell cycle progression. Journal of Immunology (Baltimore, Md. : 1950). 177: 1981-7. PMID 16849512 DOI: 10.4049/Jimmunol.177.3.1981  0.407
2006 Gajewski TF, Meng Y, Harlin H. Immune suppression in the tumor microenvironment. Journal of Immunotherapy (Hagerstown, Md. : 1997). 29: 233-40. PMID 16699366 DOI: 10.1097/01.Cji.0000199193.29048.56  0.433
2006 Peterson AC, Harlin H, Karrison T, Vogelzang NJ, Knost JA, Kugler JW, Lester E, Vokes E, Gajewski TF, Stadler WM. A randomized phase II trial of interleukin-2 in combination with four different doses of bryostatin-1 in patients with renal cell carcinoma. Investigational New Drugs. 24: 141-9. PMID 16514482 DOI: 10.1007/S10637-006-5935-4  0.356
2006 Harlin H, Kuna TV, Peterson AC, Meng Y, Gajewski TF. Tumor progression despite massive influx of activated CD8(+) T cells in a patient with malignant melanoma ascites. Cancer Immunology, Immunotherapy : Cii. 55: 1185-97. PMID 16468035 DOI: 10.1007/S00262-005-0118-2  0.481
2005 Gajewski TF, Peterson AC, Slingluff C, McKee M, Harlin H. Reciprocal expression of indoleamine-2,3-dioxygenase (IDO) and arginase-I in metastatic melanoma tumors Journal of Clinical Oncology. 23: 7523-7523. DOI: 10.1200/Jco.2005.23.16_Suppl.7523  0.305
2004 Peterson AC, Harlin H, Karrison T, Knost JA, Kugler JW, Vogelzang NJ, Vokes EE, Gajewski TF, Stadler WM. A randomized phase II trial of Interleukin-2 in combination with four different doses of bryostatin in patients with renal cell carcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 4608. PMID 28015710 DOI: 10.1200/Jco.2004.22.14_Suppl.4608  0.342
2004 Harlin H, Artz AS, Mahowald M, Rini BI, Zimmerman T, Vogelzang NJ, Gajewski TF. Clinical responses following nonmyeloablative allogeneic stem cell transplantation for renal cell carcinoma are associated with expansion of CD8+ IFN-gamma-producing T cells. Bone Marrow Transplantation. 33: 491-7. PMID 14716341 DOI: 10.1038/Sj.Bmt.1704385  0.372
2004 Harlin H, Peterson A, McKee M, Gajewski T. Melanoma Gene Expression Profiles To Identify Mechanisms of Tumor Resistance to a Multi-Peptide/IL-12 Vaccine Journal of Immunotherapy. 27. DOI: 10.1097/00002371-200411000-00165  0.315
2003 Tschoep K, Manning TC, Harlin H, George C, Johnson M, Gajewski TF. Disparate functions of immature and mature human myeloid dendritic cells: implications for dendritic cell-based vaccines. Journal of Leukocyte Biology. 74: 69-80. PMID 12832444 DOI: 10.1189/Jlb.0702352  0.352
2003 Peterson AC, Harlin H, Gajewski TF. Immunization with Melan-A peptide-pulsed peripheral blood mononuclear cells plus recombinant human interleukin-12 induces clinical activity and T-cell responses in advanced melanoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 21: 2342-8. PMID 12805336 DOI: 10.1200/Jco.2003.12.144  0.422
2002 Harlin H, Hwang KW, Palucki DA, Kim O, Thompson CB, Boothby M, Alegre ML. CTLA-4 engagement regulates NF-kappaB activation in vivo. European Journal of Immunology. 32: 2095-104. PMID 12209621 DOI: 10.1002/1521-4141(200208)32:8<2095::Aid-Immu2095>3.0.Co;2-E  0.463
2002 Harlin H, Podack E, Boothby M, Alegre ML. TCR-independent CD30 signaling selectively induces IL-13 production via a TNF receptor-associated factor/p38 mitogen-activated protein kinase-dependent mechanism. Journal of Immunology (Baltimore, Md. : 1950). 169: 2451-9. PMID 12193714 DOI: 10.4049/Jimmunol.169.5.2451  0.369
2001 Harlin H, Reffey SB, Duckett CS, Lindsten T, Thompson CB. Characterization of XIAP-deficient mice. Molecular and Cellular Biology. 21: 3604-8. PMID 11313486 DOI: 10.1128/Mcb.21.10.3604-3608.2001  0.399
Show low-probability matches.